[1]秦保锋,王明哲,龚帆,等.地黄饮子加减对急性脑梗死患者血小板聚集率及VEGF的影响[J].西部中医药,2021,34(01):95-98.[doi:10.12174/j.issn.2096-9600.2021.01.25]
　QIN Baofeng,WANG Mingzhe,GONG Fan,et al.Effects of Modified Dihuang Yingzi on Platelet Aggregation Rate and VEGF in the Patients with Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2021,34(01):95-98.[doi:10.12174/j.issn.2096-9600.2021.01.25]
点击复制

地黄饮子加减对急性脑梗死患者血小板聚集率及VEGF的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年01期
页码:
95-98
栏目:
衷中参西
出版日期:
2021-01-15

文章信息/Info

Title:
Effects of Modified Dihuang Yingzi on Platelet Aggregation Rate and VEGF in the Patients with Acute Cerebral Infarction
作者:
秦保锋, 王明哲, 龚帆, 王骏, 张红智, 郭咏梅
上海中医药大学附属曙光医院神经内科，上海 201203
Author(s):
QIN Baofeng, WANG Mingzhe, GONG Fan, WANG Jun, ZHANG Hongzhi, GUO Yongmei
Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of TCM, Shanghai 201203, China
关键词:
急性脑梗死; 血小板聚集率; 血管内皮生长因子; 地黄饮子; 临床疗效
Keywords:
acute cerebral infarction; platelet aggregation rate; VEGF; clinical effects
分类号:
R742
DOI:
10.12174/j.issn.2096-9600.2021.01.25
摘要:
目的探讨地黄饮子加减对急性脑梗死患者血小板聚集率、血管内皮生长因子(vascular endothelial growth factor，VEGF)的影响。 方法将急性脑梗死患者120例随机分为治疗组与对照组各60例，对照组予常规疗法，治疗组在对照组基础上予地黄饮子加减治疗，治疗14天后观察两组患者神经功能缺损、血小板聚集率与VEGF变化情况及安全性。 结果与治疗前比较，两组患者治疗后神经功能缺损积分减少，血小板聚集率下降，差异均有统计学意义(P＜0.05)；VEGF水平升高，对照组治疗前后比较差异无统计学意义(P＞0.05)，治疗组治疗前后比较差异有统计学意义(P＜0.05)；治疗组神经功能缺损、血小板聚集率及VEGF水平改善优于对照组，差异有统计学意义(P＜0.05)，且无明显副作用。 结论常规治疗联合地黄饮子加减可能通过调节血小板聚集功能、VEGF表达改善急脑梗死患者神经功能。
Abstract:
Objective:To study the effects of modified Dihuang Yinzi on platelet aggregation rate and vascular endothelial growth factor (VEGF) in patients with acute cerebral infarction (ACI). MethodsAll 120 ACI patients were randomly divided into the treatment group and the control group, 60 cases each group, the control group were treated by conventional therapy, and the treatment group took modified Dihuang Yinzi based on conventional therapy, to observe the changes of NIHSS, platelet aggregation rate and VEGF, and the safety in both groups 14 days after treating. ResultsAfter treating, NIHSS scores reduced and platelet aggregation rate lowered in both groups after treating, the difference had statistical meaning compared with before treating (P<0.05), VEGF levels rose, and the difference had no statistical meaning in the control group before and after treating (P>0.05), the difference was statistically significant in the treatment group before and after treating (P<0.05); the treatment group was superior to the control group in the improvements of NIHSS, platelet aggregation rate and VEGF, and there was a significant difference (P<0.05), no obvious side effects. ConclusionModified Dihuang Yinzi combined with conventional therapy could improve neurological function which might be through regulating platelet aggregation and the expressions of VEGF.

相似文献/References:

[1]刘超,李成山,李妍怡△.中风膏对缺血性脑卒中患者血小板聚集率的影响[J].西部中医药,2013,26(12):5.
　LIU Chao,LI Chengshan,LI Yanyi.Effects of ZhongFeng Ointment on Platelet Aggregation Rate of the Patients with Ischemic Stroke[J].Western Journal of Traditional Chinese Medicine,2013,26(01):5.
[2]任福军.平肝熄风汤联合西药治疗紧张型头痛的疗效及对血浆内皮素、血小板聚集率和生活质量的影响[J].西部中医药,2015,28(09):96.
[3]曹骅,张振昶.银杏二萜内酯葡胺注射液治疗急性脑梗死疗效观察[J].西部中医药,2019,32(03):74.
　CAO Hua,ZHANG Zhenchang.Clinical Observation on Treating Acute Cerebral Infarction with Ginkgo Biloba Diterpene Lactone Meglumine Injection[J].Western Journal of Traditional Chinese Medicine,2019,32(01):74.
[4]蓝雪花,陈嘉汇,覃丽容,等.中医护理在急性脑梗死患者中的应用[J].西部中医药,2019,32(08):126.
　LAN Xuehua,CHEN Jiahui,QIN Lirong,et al.The Application of TCM Nursing to the Patients Suffering Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2019,32(01):126.
[5]杨光,岳扬,才蕊.银杏叶提取物注射液联合持续正压通气治疗急性脑梗死合并OSAHS 43例[J].西部中医药,2020,33(04):99.[doi:10.12174/j.issn.1004-6852.2020.04.30]
　YANG Guang,YUE Yang,CAI Rui.Ginkgo Biloba Leaf Extract Injection Joined with Continuous Positive Airway Pressure in Treating 43 Cases of Acute Cerebral Infarction Complicated with OSAHS[J].Western Journal of Traditional Chinese Medicine,2020,33(01):99.[doi:10.12174/j.issn.1004-6852.2020.04.30]
[6]刘华,崔秀卿,邢金梅,等.银杏达莫联合丁苯酞及瑞替普酶治疗急性脑梗死临床观察[J].西部中医药,2020,33(S1):90.
　LIU Hua,CUI Xiuqing,XING Jinmei,et al.Clinical Observation on Ginkgo Leaf Extract and Dipyridamole Injection,Butylphthalide and Reteplase in Treating Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2020,33(01):90.
[7]赵琴.通痹活络汤联合依达拉奉对急性脑梗死患者血清CXCL-16、MCP-1和GDF-15的影响[J].西部中医药,2022,35(01):16.[doi:10.12174/j.issn.2096-9600.2022.01.04]
　ZHAO Qin.Effects of Tongbi Huoluo Decoction Combined with Edaravone on Serum CXCL-16, MCP-1 and GDF-15 in Patients with Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2022,35(01):16.[doi:10.12174/j.issn.2096-9600.2022.01.04]
[8]刘华,崔秀卿,邢金梅,等.银杏达莫联合丁苯酞及瑞替普酶治疗急性脑梗死临床观察[J].西部中医药,2021,34(07):98.[doi:10.12174/j.issn.2096-9600.2021.07.25]
　LIU Hua,CUI Xiuqing,XING Jinmei,et al.Clinical Observation on Ginkgo Leaf Extract and Dipyridamole Injection, Butylphthalide and Reteplase in Treating Acute Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2021,34(01):98.[doi:10.12174/j.issn.2096-9600.2021.07.25]

备注/Memo

备注/Memo:
秦保锋(1977—)，男，博士学位，副主任医师。研究方向：心脑血管病的中西医结合治疗。第六批全国老中医药专家学术经验继承项目(国中药人教发〔2017〕29号)；上海中医药大学预算内项目(2016YSN46)。
更新日期/Last Update: 2021-01-15